COA availability means a vendor publishes a document or index we can link. It does not mean pepmg certified the product, batch, safety, or authenticity.

● Seven-day market intelligence

The index is a living dataset.

Full change log →

Largest real price drop

AOD-9604 ↓30%

~~$6.75~~ → $4.75/mg at Pepvida Labs

Widest price spread

17.4×

GLP1 S · $1.55–$27.00/mg

New listings

217

added in the last 7 days

Start with a full dossier

Retatrutide

research, regulatory status, 56 vendors, and source receipts

● The credibility contract

Useful enough to rely on. Honest enough not to push.

Full disclosure →

Ranking is deterministic

Eligible rows sort by normalized $/mg. Affiliate commission is never an input.

Money is visible

Any link that ever pays pepmg is labeled beside the action, and commission never touches ranking. Non-paying rows are always visible too.

Claims carry evidence labels

Human, animal, and in-vitro findings are not collapsed into one vague “research-backed” claim.

Sources keep their limits

A vendor-hosted COA is linked and classified, never promoted as proof of safety or authenticity.

● Weekly market briefing

Follow changes in the price index.

Real repricings, new market floors, and meaningful source changes—without sponsored placements.

One useful email a week · unsubscribe anytime · research use only

Find a peptide.See every price and study.

Field Notes

Pinealon's human evidence is five Russian-language reports and a patent. The one FDA drug listing under its name registers a different peptide.

FOXO4-DRI has no published human study. Three bulk listings in FDA's drug directory carrying its name register a cat-allergen peptide as the ingredient.

One page, from literature to price comparisons.